633327-11-4

Basic information

• Product Name: 1H-Indazole-5-carbonitrile,6-fluoro-(9CI)
• Synonyms: 1H-Indazole-5-carbonitrile,6-fluoro-(9CI);6-fluoro-1H-indazole-5-carbonitrile
• CAS NO: 633327-11-4
• Molecular Formula: C8H4FN3
• Molecular Weight: 161.1358632
• Product Categories: HALIDE
• Mol File: 633327-11-4.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 367.5±22.0 °C(Predicted)
• Appearance: /
• Density: 1.44±0.1 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 11.41±0.40(Predicted)
• CAS DataBase Reference: 1H-Indazole-5-carbonitrile,6-fluoro-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Indazole-5-carbonitrile,6-fluoro-(9CI)(633327-11-4)
• EPA Substance Registry System: 1H-Indazole-5-carbonitrile,6-fluoro-(9CI)(633327-11-4)

Safety Data

• Hazardous Substances Data: 633327-11-4(Hazardous Substances Data)

Usage

General Description

1H-Indazole-5-carbonitrile,6-fluoro-(9CI) is a chemical compound with the molecular formula C9H5FN4. It is a derivative of indazole, a bicyclic aromatic heterocycle, and contains a fluorine and a nitrile group attached to the carbon atoms. 1H-Indazole-5-carbonitrile,6-fluoro-(9CI) has potential applications in the field of medicinal chemistry and drug design, due to its structural and pharmacological properties. It may be used as a building block in the synthesis of pharmaceutical compounds, or as a template for the development of novel drug candidates. Additionally, its unique structure and functional groups make it of interest for further research in the development of organic materials and chemical processes.

Upstream product

• 633335-81-6 1-(5-bromo-6-fluoro-1H-indazol-1-yl)ethan-1-one 
• 557-21-1 zinc(II) cyanide 
• 105391-70-6 5-bromo-6-fluoro-1H-indazole 
• 52723-82-7 4-bromo-5-fluoro-2-methylaniline 
• 633327-10-3 2,4-difluoro-5-formylbenzonitrile 

Downstream Products

• 1126425-15-7 6-fluoro-1H-indazole-5-carbaldehyde 

Relevant articles and documents

OXADIAZOLE SUBSTITUTED INDAZOLE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE 1 (S1P1) RECEPTOR AGONISTS

Oxadiazole substituted indazole derivatives of formula (I) or pharmaceutical salts thereof having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their uses in the treatment of various disorders mediated by S1P1 receptors are disclosed.

PYRAZOLE COMPOUND AND MEDICINAL COMPOSITION CONTAINING THE SAME

The present invention provides a novel compound having an excellent JNK inhibitory effect. That is, it provides a compound represented by the following formula, a salt thereof or a hydrate of them. Wherein R1 designates -(CO)h-(NRa)j-(CRb=CRc)k-Ar (wherein Ra, Rb and Rc each independently designate a hydrogen atom, a halogen atom, hydroxyl group, an optionally substituted C1-6 alkyl group or the like; Cy designates a 5- or 6-membered heteroaryl; and V each independently designate the formula -L-X-Y (wherein L designates a single bond, an optionally substituted C1-6 alkylene group or the like; X designates a single bond or the formula -A- (wherein A designates NR2, O, CO, S, SO or SO2) and so on; and Y designates a hydrogen atom, a halogen atom, nitro group or the like).